Poster THPE0101 XVII International AIDS Conference Early mortality (pre and post antiretroviral treatment) amongst children with HIV/AIDS enrolled in two programs in Cambodia Raguenaud.
Download ReportTranscript Poster THPE0101 XVII International AIDS Conference Early mortality (pre and post antiretroviral treatment) amongst children with HIV/AIDS enrolled in two programs in Cambodia Raguenaud.
Poster THPE0101 XVII International AIDS Conference Early mortality (pre and post antiretroviral treatment) amongst children with HIV/AIDS enrolled in two programs in Cambodia Raguenaud ME.¹, Isaakidis P.¹, Vantha T.², Seithaboth S.³, Kazumi A.³, Zachariah R4 ¹ Médecins Sans Frontières (MSF), Cambodia, ² Donkeo Referral Hospital, Ministry of Health, Takeo, Cambodia, ³ Angkor Hospital for Children, Siem Reap, Cambodia, 4 Médecins Sans Frontières, Operational Centre Brussels Death rates BACKGROUND There is very limited documented information on the importance of early mortality (death within first 6 months) among children enrolled within HIV/AIDS programs in resource-limited settings. Table. Cumulative death rates by 3 and 6 months of HIVpositive children in the Donkeo hospital and AHC. Time period OBJECTIVES We a) determined the incidence of early mortality prior to and after initiating ART and b) assessed risk factors associated with early mortality. SETTING Person-time not on ART (from screening) Deaths (% of total deaths) Personyears Rate per 100 PY 2 (1.8%) 12 (11%) 39 (36%) 37 (34%) 50 (46%) 70 (64%) 657 5.6 657 7.6 657 10.6 1443 0.1 1443 0.8 1443 2.7 Early mortality rate was 9.5 times higher in patients not treated than in patients on ART Risk factors for early mortality • In the univariate analysis, among children not on treatment, early death was associated with male sex, CDC stage C, baseline CD4 <200, CD4%<15%, admission during the early years of the program (before 2006), and W/H <-2 z-score. METHODS • Retrospective cohort study using patient data entered in HIV-specific software • All children admitted from 2002 until end 2007 included. Observation period ended in April 2008 • Cox-regression analysis done to assess for risk factors of early death • Likely cause of death assessed from patient chart review RESULTS Enrolment and follow up • Total of 1246 children enrolled in HIV program (48% girls) • 146 (12%) were <18 months, 564 (45%) 18-60months, and 536 (43%)>60months • Median CD4% 17.9 (10.0-24.2) in 18-60 months age • Median CD4 218cells/mm³(39-562) in >=5yrs age •714 (57%) started ARV treatment • Median ART initiation time: 4.8 months (IQR:2.8-9.1) • Median time from ART eligibility until ART start: 3.6 months (IQR:2.2-7.1) Children on ART 601 (84%) 13 (2%) 39 (5%) 61 (9%) Person-time on ART (from start of treatment) Deaths (% of Person Rate per total deaths) -years 100 PY 50 of 62 (82%) children who died within 6 months of enrolment in the HIV programs were not yet receiving ART •National HIV prevalence rate 0.9% (2006) • 2 programs: pediatric HIV clinic of Takeo public hospital and the HIV clinic of the charity-run ‘Angkor Hospital for Children’ in Siem Reap • Care and ART (3TC/D4T/NVP or EFV) delivered free of charge Status at end of study In active cohort Loss to follow-up Dead Transferred out Up to 90 days Up to 180 days Until end of observatio n period Among all patients (from screening) Deaths PersonRate (% of years per total 100 deaths) PY 39 2537 1.5 (36%) 62 2537 2.4 (57%) 109 2537 4.3 (100%) Children not on ART 293 (55%) 129 (24%) 70 (13%) 40 (8%) • In the multivariate analysis only blood CD4 was associated with early death: - Mortality rate ratio comparing those with CD4 cell counts <200 and ≥200 cells/mm³ was 8.10 (95%CI, 1.1-61.4) - Mortality rate ratio comparing those with CD4 % <15% and ≥15% was 11.1 (95%CI, 1.0-119.0) • 41 out of 50 (82%) children with early death before treatment met the ART eligibility criteria. • Median delay between ART eligibility date and date of death: 50 days (IQR: 24-74) Cause of early death Cause of death All patients (n=62) Tuberculosis Lower respiratory tract infection Wasting syndrome Other Unknown 28 (45.2) 16 (25.8) 7 (11.3) 7 (11.3) 4 (6.4) Patients receiving ART (n=12) 6 (50.0) 3 (25.0) Patients not receiving ART (n=50) 22 (44.0) 13 (26.0) 2 (16.7) 1 (8.3) 5 (10.0) 6 (12.0) 4 (8.0) Conclusions Most deaths among children enrolled in two program settings in Cambodia occur within the first 6 months after enrolment. Early mortality rates were more than nine-fold higher among children not yet initiated on ART compared to those placed on treatment. Urgent measures to promptly initiate ART in eligible children should be taken such as a fasttrack procedure, earlier preparatory counselling sessions, improved access to laboratory tests and results, systematic HIV screening in children diagnosed with TB and considering early ART initiation among children treated for TB.